scispace - formally typeset
E

Eric R. Welin

Researcher at California Institute of Technology

Publications -  9
Citations -  896

Eric R. Welin is an academic researcher from California Institute of Technology. The author has contributed to research in topics: Enantioselective synthesis & Organocatalysis. The author has an hindex of 6, co-authored 9 publications receiving 562 citations. Previous affiliations of Eric R. Welin include Ohio State University & University of Washington.

Papers
More filters
Journal ArticleDOI

Photosensitized, energy transfer-mediated organometallic catalysis through electronically excited nickel(II).

TL;DR: Here, excited-state organometallic catalysis via direct photoexcitation is demonstrated via such an activation pathway, and detailed mechanistic studies confirm the role of photosensitization via energy transfer.
Journal ArticleDOI

Advances in Stereoconvergent Catalysis from 2005 to 2015: Transition-Metal-Mediated Stereoablative Reactions, Dynamic Kinetic Resolutions, and Dynamic Kinetic Asymmetric Transformations

TL;DR: This Review summarizes major advances in nonenzymatic, transition-metal-promoted dynamic asymmetric transformations reported between 2005 and 2015.
Journal ArticleDOI

Enantioselective α-Alkylation of Aldehydes by Photoredox Organocatalysis: Rapid Access to Pharmacophore Fragments from β-Cyanoaldehydes

TL;DR: The combination of photoredox catalysis and enamine catalysis has enabled the development of an enantioselective α-cyanoalkylation of aldehydes, allowing rapid diversification of the oxonitrile products to a wide array of medicinally relevant derivatives and heterocycles.
Journal ArticleDOI

Radical philicity and its role in selective organic transformations

TL;DR: In this paper, the authors present a qualitative method to understand and predict radical philicity by classifying the typical reactivity of more than 30 types of radicals into nucleophilic or electrophilic behaviour.
Journal ArticleDOI

Concise total syntheses of (─)-jorunnamycin A and (─)-jorumycin enabled by asymmetric catalysis

TL;DR: An approach to two bis-THIQ natural products, jorunnamycin A and jorumycin, that instead harnesses the power of modern transition-metal catalysis for the three major bond-forming events and proceeds with high efficiency, allowing for the preparation of a more diverse set of nonnatural analogs.